Low-dose atropine eye drops for children with myopia in the UK
Research type
Research Study
Full title
Low-dose atropine eye drops to reduce progression of myopia in children: a multi-centre placebo controlled randomised trial in the United Kingdom (CHAMP UK)
IRAS ID
220664
Contact name
Augusto Azuara-Blanco
Contact email
Sponsor organisation
Belfast Health and Social Care Trust
Eudract number
2017-004108-23
Duration of Study in the UK
6 years, 8 months, 31 days
Research summary
Short-sightedness, also called myopia, makes objects in the distance, such as the television, look blurred. This is caused by the eye growing too long, something that usually happens while children are also getting taller. People with myopia can see better with glasses or contact lenses, but this doesn’t stop their eyes continuing to become more short-sighted. The CHAMP UK study is investigating a type of eye drop called atropine that might help to stop myopia getting worse as children get older.
REC name
HSC REC B
REC reference
18/NI/0164
Date of REC Opinion
2 Oct 2018
REC opinion
Further Information Favourable Opinion